aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet

RxCUI: 1536993
RxNorm name: aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet
Term type: SCD
Status: Active
Updated: 2026-09-25 04:21:48

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 062014
Active start: 062014
Multiple ingredient: YES
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
aspirin	500 MG / 1 EACH	aspirin	aspirin
chlorpheniramine maleate	2 MG / 1 EACH	chlorpheniramine	chlorpheniramine maleate
phenylephrine bitartrate	8 MG / 1 EACH	phenylephrine	phenylephrine bitartrate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Effervescent Oral Tablet	1535727

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
aspirin	1191
chlorpheniramine	2400
phenylephrine	8163

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
RXNAV_STR	aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet	1	NAMES
RxNorm Name	aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet	1	NAMES
RxNorm Synonym	ASA 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine bitartrate 8 MG Effervescent Oral Tablet	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	0039fee5-35a8-429b-a1cf-7b4bf1f8a6e7	1	CODES
RxCUI	1536993	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
53666040812	rxnav_ndcs	yes
53666040815	rxnav_historical_indirect
53666044412	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
0039fee5-35a8-429b-a1cf-7b4bf1f8a6e7	aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet [PSN] · aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet [SCD] · ASA 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine bitartrate 8 MG Effervescent Oral Tablet [SY]	3	7	TABCIN 500	20130912
2e946175-5aaa-4cf2-bf71-680d591dc434	aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet [PSN] · aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet [SCD] · ASA 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine bitartrate 8 MG Effervescent Oral Tablet [SY]	3	1	TABCIN	20130828

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
0039fee5-35a8-429b-a1cf-7b4bf1f8a6e7	TABCIN 500	Salimex, S.A. \| Bayer de Mexico, S.A. de CV	20130912
2e946175-5aaa-4cf2-bf71-680d591dc434	TABCIN	Salimex, S.A. \| Bayer de Mexico, S.A. de CV	20130828

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	C01CA	Adrenergic and dopaminergic agents	ATC1-4		phenylephrine
ATC	A01AD	Other agents for local oral treatment	ATC1-4		aspirin
ATC	C05AX	Other agents for treatment of hemorrhoids and anal fissures for topical use	ATC1-4		phenylephrine
ATC	B01AC	Platelet aggregation inhibitors excl. heparin	ATC1-4		aspirin
ATC	N02BA	Salicylic acid and derivatives	ATC1-4		aspirin
ATC	R06AB	Substituted alkylamines	ATC1-4		chlorpheniramine
ATC	R01BA	Sympathomimetics	ATC1-4		phenylephrine
ATC	S01FB	Sympathomimetics excl. antiglaucoma preparations	ATC1-4		phenylephrine
ATC	S01GA	Sympathomimetics used as decongestants	ATC1-4		phenylephrine
ATC	R01AB	Sympathomimetics, combinations excl. corticosteroids	ATC1-4		phenylephrine
ATC	R01AA	Sympathomimetics, plain	ATC1-4		phenylephrine
FDASPL	N0000186105	alpha-1 Adrenergic Agonist	EPC	has_epc	phenylephrine
FDASPL	N0000175587	Histamine-1 Receptor Antagonist	EPC	has_epc	chlorpheniramine
FDASPL	N0000175722	Nonsteroidal Anti-inflammatory Drug	EPC	has_epc	aspirin
FDASPL	N0000175578	Platelet Aggregation Inhibitor	EPC	has_epc	aspirin
MEDRT	D001241	Aspirin	CHEM	has_ingredient	aspirin
MEDRT	D002744	Chlorpheniramine	CHEM	has_ingredient	chlorpheniramine
MEDRT	D002744	Chlorpheniramine	CHEM	has_ingredient	chlorpheniramine maleate
MEDRT	D010656	Phenylephrine	CHEM	has_ingredient	phenylephrine
MEDRT	D013447	Sulfites	CHEM	ci_chemclass	phenylephrine
MEDRT	D013447	Sulfites	CHEM	ci_chemclass	phenylephrine bitartrate
MEDRT	D001172	Arthritis, Rheumatoid	DISEASE	may_treat	aspirin
MEDRT	D001778	Blood Coagulation Disorders	DISEASE	ci_with	aspirin
MEDRT	D001791	Blood Platelet Disorders	DISEASE	ci_with	aspirin
MEDRT	D002544	Cerebral Infarction	DISEASE	may_prevent	aspirin
MEDRT	D002644	Chickenpox	DISEASE	ci_with	aspirin
MEDRT	D002675	Child, Preschool	DISEASE	ci_with	aspirin
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	aspirin
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	chlorpheniramine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenylephrine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenylephrine bitartrate
MEDRT	D004380	Duodenal Obstruction	DISEASE	ci_with	chlorpheniramine
MEDRT	D004380	Duodenal Obstruction	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D005334	Fever	DISEASE	may_treat	aspirin
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	phenylephrine
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D015812	Glaucoma, Angle-Closure	DISEASE	ci_with	chlorpheniramine
MEDRT	D015812	Glaucoma, Angle-Closure	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D005902	Glaucoma, Open-Angle	DISEASE	may_treat	phenylephrine
MEDRT	D005902	Glaucoma, Open-Angle	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D006073	Gout	DISEASE	may_treat	aspirin
MEDRT	D006396	Hematemesis	DISEASE	ci_with	aspirin
MEDRT	D006474	Hemorrhagic Disorders	DISEASE	ci_with	aspirin
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	phenylephrine
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D006973	Hypertension	DISEASE	ci_with	phenylephrine bitartrate
MEDRT	D006973	Hypertension	DISEASE	ci_with	phenylephrine
MEDRT	D007022	Hypotension	DISEASE	may_treat	phenylephrine
MEDRT	D007022	Hypotension	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D007223	Infant	DISEASE	ci_with	aspirin
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	chlorpheniramine
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D007234	Infant, Premature	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D007234	Infant, Premature	DISEASE	ci_with	chlorpheniramine
MEDRT	D007249	Inflammation	DISEASE	may_treat	aspirin
MEDRT	D002546	Ischemic Attack, Transient	DISEASE	may_prevent	aspirin
MEDRT	D008551	Melena	DISEASE	ci_with	aspirin
MEDRT	D015878	Mydriasis	DISEASE	induces	phenylephrine
MEDRT	D015878	Mydriasis	DISEASE	induces	phenylephrine bitartrate
MEDRT	D009203	Myocardial Infarction	DISEASE	may_prevent	aspirin
MEDRT	D009298	Nasal Polyps	DISEASE	ci_with	aspirin
MEDRT	D010003	Osteoarthritis	DISEASE	may_treat	aspirin
MEDRT	D010146	Pain	DISEASE	may_treat	aspirin
MEDRT	D010146	Pain	DISEASE	may_prevent	aspirin
MEDRT	D010437	Peptic Ulcer	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D010437	Peptic Ulcer	DISEASE	ci_with	chlorpheniramine
MEDRT	D011225	Pre-Eclampsia	DISEASE	may_prevent	aspirin
MEDRT	D011263	Pregnancy Trimester, Third	DISEASE	ci_with	aspirin
MEDRT	D011470	Prostatic Hyperplasia	DISEASE	ci_with	chlorpheniramine
MEDRT	D011470	Prostatic Hyperplasia	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	phenylephrine
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D012213	Rheumatic Fever	DISEASE	may_treat	aspirin
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	chlorpheniramine
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	chlorpheniramine maleate
MEDRT	D012223	Rhinitis, Vasomotor	DISEASE	may_treat	phenylephrine
MEDRT	D012223	Rhinitis, Vasomotor	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D012772	Shock, Septic	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D012772	Shock, Septic	DISEASE	may_treat	phenylephrine
MEDRT	D013224	Status Asthmaticus	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D013224	Status Asthmaticus	DISEASE	ci_with	chlorpheniramine
MEDRT	D013617	Tachycardia, Supraventricular	DISEASE	may_treat	phenylephrine
MEDRT	D013617	Tachycardia, Supraventricular	DISEASE	may_treat	phenylephrine bitartrate
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	ci_with	phenylephrine bitartrate
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	ci_with	phenylephrine
MEDRT	D001748	Urinary Bladder Neck Obstruction	DISEASE	ci_with	chlorpheniramine maleate
MEDRT	D001748	Urinary Bladder Neck Obstruction	DISEASE	ci_with	chlorpheniramine
MEDRT	D014581	Urticaria	DISEASE	may_treat	chlorpheniramine maleate
MEDRT	D014581	Urticaria	DISEASE	may_treat	chlorpheniramine
MEDRT	N0000000209	Adrenergic alpha-Agonists	MOA	has_moa	phenylephrine bitartrate
MEDRT	N0000000209	Adrenergic alpha-Agonists	MOA	has_moa	phenylephrine
MEDRT	N0000000160	Cyclooxygenase Inhibitors	MOA	has_moa	aspirin
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	chlorpheniramine
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	chlorpheniramine maleate
MEDRT	N0000008371	Conjunctival Arterial Vasoconstriction	PE	has_pe	phenylephrine
MEDRT	N0000008371	Conjunctival Arterial Vasoconstriction	PE	has_pe	phenylephrine bitartrate
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	chlorpheniramine
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	chlorpheniramine maleate
MEDRT	N0000008896	Decreased Nasal and Sinus Secretions	PE	has_pe	phenylephrine
MEDRT	N0000008896	Decreased Nasal and Sinus Secretions	PE	has_pe	phenylephrine bitartrate
MEDRT	N0000008831	Decreased Platelet Activating Factor Production	PE	has_pe	aspirin
MEDRT	N0000008832	Decreased Platelet Aggregation	PE	has_pe	aspirin
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	aspirin
MEDRT	N0000009006	Decreased Thromboxane Production	PE	has_pe	aspirin
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	aspirin
MEDRT	N0000000042	Renal Excretion	PK	has_pk	aspirin

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Effervescent Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
IN	IN	aspirin	rxnav_allrelated
IN	IN	chlorpheniramine	rxnav_allrelated
IN	IN	phenylephrine	rxnav_allrelated
MIN	MIN	aspirin / chlorpheniramine / phenylephrine	rxnav_allrelated
PIN	PIN	chlorpheniramine maleate	rxnav_allrelated
PIN	PIN	phenylephrine bitartrate	rxnav_allrelated
SCD	SCD	aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet	rxnav_allrelated
SCDC	SCDC	aspirin 500 MG	rxnav_allrelated
SCDC	SCDC	chlorpheniramine maleate 2 MG	rxnav_allrelated
SCDC	SCDC	phenylephrine bitartrate 8 MG	rxnav_allrelated
SCDF	SCDF	aspirin / chlorpheniramine / phenylephrine Effervescent Oral Tablet	rxnav_allrelated
SCDFP	SCDFP	aspirin / chlorpheniramine maleate / phenylephrine bitartrate Effervescent Oral Tablet	rxnav_allrelated
SCDG	SCDG	aspirin / chlorpheniramine / phenylephrine Oral Product	rxnav_allrelated
SCDGP	SCDGP	aspirin / chlorpheniramine maleate / phenylephrine bitartrate Oral Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	500 MG / 2 MG / 8 MG
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
NAMES	Prescribable Synonym	aspirin 500 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 8 MG Effervescent Oral Tablet
SOURCES	Source	Metathesaurus FDA Structured Product Labels